A word about nomenclature
• Chromosome 22q11.2 deletion syndrome
• DiGeorge syndrome
• Velocardiofacial syndrome
• Conotruncal anomaly face
• Some CHARGE
The majority of patients with DiGeorge syndrome, VCFS, CTAF have hemizygous deletions of chromosome 22q11.2. The nomenclature is not synonymous.
The Phenotype of Chromosome 22q11.2 Deletion Syndrome
• Cardiac anomaly 75%
– TOF-20%
– IAA-15%
– Truncus arteriosus-8%
• Palatal anomaly-69-100%
• Hypocalcemia-17-60%
• Speech delay-75%
• Renal anomaly-36-37%
• Skeletal anomaly-17-19%
• Immunodeficiency-60-77%
Where to look for the deletion?
Cardiac Diseases
Any cardiac lesion-1.1%
Interrupted aortic arch-50-60%
Pulmonary atresia-33-45%
Aberrant subclavian-25%
Tetralogy of Fallot-11-17%
Others
Velopharyngeal insufficiency following adnoidectomy-64%
Isolated velopharyngeal insufficiency-37%
Neonatal hypocalcemia-74%
Schizophrenia-0.3-6.4%
The diagnosis is established by FISH
22 well-characterized genes
The critical region was established by generating mice with comparable deletions
The Heterozygous Murine Deletion
25-50% of mice have cardiovascular anomalies
o Aberrant great vessels (right subclavian, IAAB)
o VSDs
o Conotruncal anomalies rare
Thymus was variably effected depending on background strain
Parathyroid gland variable
Homozygous mice have additional features of Ch22q11.2 D
Tbx-1
• Expressed in developing mesenchyme
• Expressed in pharyngeal arches, otic vesicle, tooth buds, sclerotome
• Heterozygous mutations of Tbx-1 are associated with great vessel defects in mice
• Homozygous deficient mice have a small mandible, low set ears, a single cardiac outflow tract, deficient thymus/parathyroid/salivary glands
TBX1 in humans
More than TBX1?
• COMT, GPIBB may modify the phenotype
• Background genes outside the deleted region may modify the phenotype
The significance of establishing the diagnosis
Toddlers
– 79% significant motor delay
– 53% significant expressive delay
– 26% significant receptive delay
School-age
– 12.7% average IQ (Weschler)
– 25.5% low average
– 34.5% borderline
– 27.3% retarded
Behavior/School issues
• 65.5% have a nonverbal learning disability
• 25% have ADHD
• 6-30% will develop schizophrenia
The Immunodeficiency of Chromosome 22q11.2 Deletion Syndrome
• 60-77% of patients have laboratory evidence of quantitative T cell defects
• Only 0.5-1.0% have absent T cells
• T cell proliferation is usually normal
• 2-4% are IgA deficient
• 10% have delayed production of IgG
The Role of the Thymus in the Immunodeficiency
– 15-20% of patients have an absent anatomic thymus
– Thymic tissue is found in aberrant locations
– Only 0.5-1.0% of patients have no T cells and truly have thymic aplasia
80% of patients have thymic hypoplasia
• Restricts T cell output
• T cells are qualitatively normal
• CD4/CD25 T cells are markedly decreased
• There can be secondary effects on antibody production
Clinical Immunodeficiency
7% of all ages have significant, serious infections
9% have autoimmune disease
Older children and adults continue to get infections
27% recurrent sinusitis
25% recurrent otitis media
7% recurrent bronchitis
4% recurrent pneumonia
Autoimmunity
• JRA is seen 20X more frequently (2%)
• ITP is seen 200X more frequently (4%)
• AHA, IBD are seen in about 1%
• Older patients develop autoimmune diseases of adults
T cell findings
• The mean T cell number is about 50% of normal in infancy
• The mean T cell number is about 80% of normal in adulthood
• Why are the adults sick so much?
This is great, such an interesting and so important to raise awareness of 22q11-2-deletion: https://fdna.health/syndromes/22q11-2-deletion-syndrome/
BalasHapus